Compare BCE & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCE | GEHC |
|---|---|---|
| Founded | 1880 | 1892 |
| Country | Canada | United States |
| Employees | 38683 | N/A |
| Industry | | Computer Software: Prepackaged Software |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2B | 27.9B |
| IPO Year | N/A | 2022 |
| Metric | BCE | GEHC |
|---|---|---|
| Price | $22.78 | $70.11 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 13 |
| Target Price | $30.50 | ★ $88.38 |
| AVG Volume (30 Days) | 3.5M | ★ 5.5M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | ★ 5.50% | 0.24% |
| EPS Growth | N/A | ★ 4.84 |
| EPS | N/A | ★ 0.85 |
| Revenue | N/A | ★ $20,625,000,000.00 |
| Revenue This Year | $3.56 | $7.12 |
| Revenue Next Year | $1.70 | $4.45 |
| P/E Ratio | ★ $5.19 | $82.64 |
| Revenue Growth | N/A | ★ 4.84 |
| 52 Week Low | $20.87 | $58.75 |
| 52 Week High | $26.52 | $89.77 |
| Indicator | BCE | GEHC |
|---|---|---|
| Relative Strength Index (RSI) | 56.72 | 63.39 |
| Support Level | $22.36 | $69.17 |
| Resistance Level | $24.02 | $72.77 |
| Average True Range (ATR) | 0.41 | 1.89 |
| MACD | 0.16 | 0.81 |
| Stochastic Oscillator | 98.54 | 90.62 |
BCE provides wireless, broadband, television, and landline phone services in Canada. It is one of the Big Three national wireless carriers, with over 10 million customers constituting about 30% of the market. It is also the incumbent local exchange carrier—the legacy telephone provider—throughout much of the eastern half of Canada, including in the most populous Canadian provinces: Ontario and Quebec. BCE has a media segment that holds television, radio, and digital media assets. BCE licenses the Canadian rights to HBO Max and Starz.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17%, respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one-third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).